148 related articles for article (PubMed ID: 1969335)
1. Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.
Ferrarini M; Steen V; Medsger TA; Whiteside TL
Clin Exp Immunol; 1990 Mar; 79(3):346-52. PubMed ID: 1969335
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
Kondo H; Rabin BS; Rodnan GP
J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
[TBL] [Abstract][Full Text] [Related]
5. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
6. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
7. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
[TBL] [Abstract][Full Text] [Related]
8. Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.
Chizzolini C; Parel Y; Scheja A; Dayer JM
Arthritis Res Ther; 2006; 8(1):R10. PubMed ID: 16356198
[TBL] [Abstract][Full Text] [Related]
9. Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.
Hussein MR; Hassan HI; Hofny ER; Elkholy M; Fatehy NA; Abd Elmoniem AE; Ezz El-Din AM; Afifi OA; Rashed HG
J Clin Pathol; 2005 Feb; 58(2):178-84. PubMed ID: 15677539
[TBL] [Abstract][Full Text] [Related]
10. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.
Mavalia C; Scaletti C; Romagnani P; Carossino AM; Pignone A; Emmi L; Pupilli C; Pizzolo G; Maggi E; Romagnani S
Am J Pathol; 1997 Dec; 151(6):1751-8. PubMed ID: 9403725
[TBL] [Abstract][Full Text] [Related]
11. T cell repertoire in patients with stable scleroderma.
Tiev KP; Abriol J; Burland MC; Antonelli D; Klatzmann D; Cabane J; Boyer O
Clin Exp Immunol; 2005 Feb; 139(2):348-54. PubMed ID: 15654834
[TBL] [Abstract][Full Text] [Related]
12. Production of a glycosaminoglycan stimulatory factor by cloned human T lymphocytes activated in vitro.
Tsao M; Zeevi A; Whiteside TL
Arthritis Rheum; 1986 Sep; 29(9):1071-7. PubMed ID: 3489466
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity among CD4+ T-cell clones from blood and skin lesions of leprosy patients. Identification of T-cell clones distinct from Th0, Th1 and Th2.
Howe RC; Wondimu A; Demissee A; Frommel D
Immunology; 1995 Apr; 84(4):585-94. PubMed ID: 7790032
[TBL] [Abstract][Full Text] [Related]
14. Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.
Fraticelli P; De Vita S; Franzolini N; Svegliati S; Scott CA; Tonnini C; Spadoni T; Gabrielli B; Pomponio G; Moroncini G; Gabrielli A
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S160-7. PubMed ID: 26339895
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation.
Yoshizaki A; Yanaba K; Iwata Y; Komura K; Ogawa A; Muroi E; Ogawa F; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Ann Rheum Dis; 2011 Jan; 70(1):194-200. PubMed ID: 20705635
[TBL] [Abstract][Full Text] [Related]
16. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
[TBL] [Abstract][Full Text] [Related]
17. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
[TBL] [Abstract][Full Text] [Related]
18. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
Gruschwitz M; Sepp N; Kofler H; Wick G
Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
[TBL] [Abstract][Full Text] [Related]
19. Skin resident memory T-cell population is not constructed effectively in systemic sclerosis.
Koguchi-Yoshioka H; Watanabe R; Fujisawa Y; Ishitsuka Y; Nakamura Y; Okiyama N; Fujimoto M
Br J Dermatol; 2019 Jan; 180(1):219-220. PubMed ID: 30120898
[No Abstract] [Full Text] [Related]
20. New insights into CD4(+) T cell abnormalities in systemic sclerosis.
Liu M; Wu W; Sun X; Yang J; Xu J; Fu W; Li M
Cytokine Growth Factor Rev; 2016 Apr; 28():31-6. PubMed ID: 26724976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]